Skip to content

Break Up Big Medicine Act

In committee: it can still change before the session ends.

US S 3822 · Senate Bill · 119th Congress

Stage
In committee
Started in
Senate
Sponsors
2
Latest action
Feb 10, 2026

What it does

The Break Up Big Medicine Act would prohibit common ownership between pharmacy benefit managers, insurers, or prescription drug and medical device wholesalers and certain medical service providers, such as physicians, pharmacies, or management services organizations, to eliminate conflicts of interest and restore competition in the health care market. It requires entities in violation to divest either their ownership of medical providers or their ownership of insurance, pharmacy benefit managers, or wholesalers within one year of enactment. The bill authorizes the Federal Trade Commission and Department of Justice to enforce these prohibitions, issue guidance, impose penalties for…

AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Feb 10, 2026

  2. Committee (Current step)

    In committee · Feb 10, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Break Up Big Medicine Act | 52